Xstrahl (BHW OncoScience)
Precision oncology through technology, training, and implementation
BHW OncoScience is the oncology and radiotherapy division of BHW Bayerische Heilmittel Wissenschaften GmbH, dedicated to expanding access to precise, evidence-based cancer care. The unit integrates technology selection, clinical protocols, facility enablement, and ongoing support to help providers deliver safe, reproducible treatments with measurable outcomes.
Leadership
The division is led by our in-house oncological radiotherapists, who oversee clinical model design, treatment-pathway development, and physician education. Under their direction, BHW OncoScience bridges industry, healthcare institutions, and regulators to accelerate the adoption of modern, non-invasive radiotherapy.
Inside BHW OncoScience
Strategic Scope & Territories
BHW OncoScience develops specialized treatment centers and distributes advanced radiotherapy systems in select markets, with an initial emphasis on Egypt and the wider MENA region. In these territories, the division coordinates with ministries of health, regulators, and hospital groups to align technology deployment with local clinical needs and infrastructure.
Clinical Focus Areas
- Skin oncology (e.g., basal cell carcinoma, squamous cell carcinoma)
- Cutaneous lymphomas and selected benign/precancerous dermatoses (per local guidelines)
- Palliative and symptom-relief indications where superficial or orthovoltage X-ray therapy is clinically appropriate
Technology Portfolio (with Xstrahl Systems)
- Superficial and orthovoltage X-ray therapy platforms for dermatologic and selected oncologic applications.
- Treatment planning workflows designed for consistent dose delivery and reproducibility.
- Integrated shielding guidance, acceptance/commissioning support, and quality-assurance (QA) frameworks aligned with recognized professional guidance (e.g., IAEA / ESTRO / AAPM).
What BHW OncoScience Provides
- Site needs assessment, patient-volume modeling, and service-line design.
- Room layout guidance and radiation-shielding calculations in collaboration with licensed physics partners.
- Care-pathway mapping from referral to follow-up, including documentation templates and consent forms.
- Support with device registration, importation dossiers, and hospital licensing requirements.
- CE-marked device documentation handling and alignment with international treatment standards.
- Safety culture programs, incident-reporting procedures, and audit readiness.
- Delivery coordination, acceptance testing, and baseline dosimetry / beam characterization with qualified experts.
- Routine QA program setup (daily / weekly / monthly / annual checks), record-keeping, and KPI dashboards.
- Preventive maintenance schedules and service escalation pathways.
- Multidisciplinary training for radiation oncologists, medical physicists, therapists, and nursing staff.
- Standard operating procedures (SOPs), clinical protocols, and patient selection criteria aligned with local standards of care.
- Proctored case starts and post-go-live support.
- Spare parts, consumables, and calibration services coordination.
- Software updates and enhancements where applicable.
- Continuous professional development: workshops, clinical case reviews, and research collaboration avenues.
Quality & Patient Safety
BHW OncoScience embeds quality from day one through structured SOPs, double-check processes, and periodic audits. Facilities are supported to implement robust QA and radiation-safety programs, with traceable documentation and continuous improvement loops.
Access & Impact
By pairing appropriate technology with capacity building, BHW OncoScience helps health systems open or expand radiotherapy services that are:
- Clinically targeted – focused on skin and selected superficial indications.
- Efficient to set up and operate within existing hospital footprints.
- Scalable across regional networks to reduce patient travel and wait times.
Xstrahl Technology in Clinical Practice
Partnership Model
We work with public and private providers, academic centers, and NGOs through flexible models:
- Turnkey clinic enablement.
- Technology distribution with training bundles.
- Long-term managed-service support.
All models are tailored to local regulations and clinical priorities.
KPIs We Help Institutions Track
- Time-to-therapy (referral to first treatment).
- Protocol adherence and QA pass rates.
- Unplanned treatment interruptions and service uptime.
- Patient-reported outcomes and satisfaction metrics.
Next Steps in MENA
BHW OncoScience is actively collaborating with clinical leaders and authorities to expand access to superficial and orthovoltage radiotherapy for skin cancers and cutaneous lymphomas. Pilot reference sites are prioritized to serve as regional training hubs and centers of excellence.
Contact
For more information, collaboration opportunities, or to discuss potential projects, please contact:
